As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Announcement
BMC Series Focus Issues
April: Genome editing
To commemorate World DNA Day celebrated annually on 25th of April, read this month's selection of articles on genome editing from across the BMC Series Journals.
Featured Article
Back to topA new method for cheaper and longer-lasting vaccines
A recent article published in BMC Biotechnology explores a new method to build longer lasting thermo-stable vaccines for a fraction of the cost. Read the full article here.
Articles
-
-
Lentivirus expressing shRNAs inhibit the replication of contagious ecthyma virus by targeting DNA polymerase gene
-
A novel family of expression vectors with multiple affinity tags for wheat germ cell-free protein expression
-
Development and biological activity of long-acting recombinant human interferon-α2b
-
Optimised production of an anti-fungal antibody in Solanaceae hairy roots to develop new formulations against Candida albicans
-
An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol
-
FastCloning: a highly simplified, purification-free, sequence- and ligation-independent PCR cloning method
-
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
-
Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells
-
Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies
Aims and scope
BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.
Editor
- Akila Sridhar, BioMed Central, UK
Manuscript Editor
- Anna Melidoni, BioMed Central, UK
Assistant Editor
- Lauren McMillan, BioMed Central, UK
Section Editors
- Joaquim M Cabral, Instituto Superior Tecnico
- Dennis Claessen, Leiden University
- Peter J Punt, TNO Microbiology & Systems Biology/Leiden University
- Marko Radic, University of Tennessee
- John J Rossi, Beckman Research Institute City of Hope
- Igor Stagljar, University of Toronto
- Hyung Joon Cha, Pohang University of Science and Technology
- Ting Lu, University of Illinois at Urbana-Champaign
Peter Punt
Peter J. Punt, PhD is Chief Technology Officer of Dutch DNA Biotech BV, a fungal biotechnology technology provider and contract research company situated in the Netherlands. In 2008 he was appointed at Leiden University in the chair of Industrial Biotechnology He joined BMC Biotechnology as a Section Editor in 2012.
BMC Series blog
-
-
Combatting a sweet tooth: the role of health marketing
31 March 2020
-
Advertisement
Follow
2018 Journal Metrics
-
Citation Impact
2.303 - 2-year Impact Factor
2.861 - 5-year Impact Factor
0.916 - Source Normalized Impact per Paper (SNIP)
1.006 - SCImago Journal Rank (SJR)
Usage
715,050 Downloads
250 Altmetric Mentions
Advertisement
